Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Albert Sjoerdsma.

Lovenberg WM, Robinson DS.

Neuropsychopharmacology. 2015 Dec;40(13):3061. doi: 10.1038/npp.2015.303. No abstract available.

2.
3.

Angiotensin converting activity assessed in vivo is increased in hereditary hypertensive rats.

Krieger EM, Yamori Y, Lovenberg WM.

Braz J Med Biol Res. 1992;25(12):1215-22.

PMID:
1341916
4.

Endothelin: a review of its effects and possible mechanisms of action.

Lovenberg W, Miller RC.

Neurochem Res. 1990 Apr;15(4):407-17. Review.

PMID:
2167457
5.

HIV-1 protease: mutagenesis of asparagine 88 indicates a domain required for dimer formation.

Guenet C, Leppik RA, Pelton JT, Moelling K, Lovenberg W, Harris BA.

Eur J Pharmacol. 1989 Dec 5;172(6):443-51.

PMID:
2693124
7.

Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase.

Sleight AJ, Marsden CA, Palfreyman MG, Mir AK, Lovenberg W.

Eur J Pharmacol. 1988 Sep 23;154(3):255-61.

PMID:
3234480
8.

Dystonia with marked diurnal variation associated with biopterin deficiency.

Fink JK, Barton N, Cohen W, Lovenberg W, Burns RS, Hallett M.

Neurology. 1988 May;38(5):707-11.

PMID:
2452381
10.

Pterin abnormalities in dystonia: a metabolic marker with therapeutic implications.

LeWitt PA, Miller LP, Levine RA, Lovenberg W, Newman RP, Papavasiliou A, Rayes A, Eldridge R, Burns RS.

Adv Neurol. 1988;50:193-201. No abstract available.

PMID:
2456675
11.
12.

Rapid purification and revised amino-terminal sequence of hirudin: a specific thrombin inhibitor of the bloodsucking leech.

Mao SJ, Yates MT, Blankenship DT, Cardin AD, Krstenansky JL, Lovenberg W, Jackson RL.

Anal Biochem. 1987 Mar;161(2):514-8.

PMID:
3578808
13.
14.

Animal models for hypertension research.

Lovenberg W.

Prog Clin Biol Res. 1987;229:225-40. No abstract available.

PMID:
3601986
15.

Biochemistry of the nervous system.

Velletri PA, Lovenberg W.

Adv Clin Chem. 1987;26:79-155. Review. No abstract available.

PMID:
2888268
16.
17.

Inhibition of K+-stimulated [3H]dopamine and [14C]acetylcholine release by the putative dopamine autoreceptor agonist, B-HT 920.

Schmidt CJ, Lobur A, Lovenberg W.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):377-82.

PMID:
2434870
18.

Genetic rat models for hypertension: guidelines for breeding, care and use.

Horan MJ, Lovenberg W.

J Hypertens Suppl. 1986 Oct;4(3):S7-9.

PMID:
3465916
19.

The importance of rat models in hypertension research.

Lovenberg W.

J Hypertens Suppl. 1986 Oct;4(3):S3-6. No abstract available.

PMID:
3465903
20.

Comparison of various genetic hypertensive rat strains.

Horie R, Kihara M, Lovenberg W, Ben-Ishay D, Bianchi G, Iwai J, Nagaoka A, Rapp JP, Sassard J, Simpson FO, et al.

J Hypertens Suppl. 1986 Oct;4(3):S11-4.

PMID:
3465895
21.

Increased non-collagen protein synthesis in the posterior cerebral artery in spontaneously hypertensive rats.

Nakada T, Kimura M, Watanabe H, Yamori Y, Lovenberg W.

J Hypertens Suppl. 1986 Oct;4(3):S93-5.

PMID:
3097282
22.

Calcium channel agonists and antagonists regulate protein phosphorylation in intact synaptosomes.

Robinson PJ, Lovenberg W.

Neurosci Lett. 1986 Jul 11;68(1):1-6.

PMID:
2425304
23.

Tetrahydrobiopterin in dystonia: identification of abnormal metabolism and therapeutic trials.

LeWitt PA, Miller LP, Levine RA, Lovenberg W, Newman RP, Papavasiliou A, Rayes A, Eldridge R, Burns RS.

Neurology. 1986 Jun;36(6):760-4.

PMID:
3703282
24.

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.

Schmidt CJ, Wu L, Lovenberg W.

Eur J Pharmacol. 1986 May 13;124(1-2):175-8.

PMID:
2424776
25.

Biochemical regulation of brain function.

Lovenberg WM.

Nutr Rev. 1986 May;44 Suppl:6-11. Review. No abstract available.

PMID:
2908800
26.

Evidence for a specific effect of BHT 920, an azepine derivative, on tyrosine hydroxylase in the dopaminergic system of the rat.

Jennewein HM, Bruckwick EA, Hanbauer I, Mierau J, Lovenberg W.

Eur J Pharmacol. 1986 Apr 29;123(3):363-9.

PMID:
2873043
27.

Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.

Burcher E, Buck SH, Lovenberg W, O'Donohue TL.

J Pharmacol Exp Ther. 1986 Mar;236(3):819-31.

PMID:
2419545
28.

Tetrahydrobiopterin administration to rhesus macaques. Its appearance in CSF and effect on neurotransmitter synthesis.

Miller L, Insel T, Scheinin M, Aloi J, Murphy DL, Linnoila M, Lovenberg W.

Neurochem Res. 1986 Feb;11(2):291-8.

PMID:
2871499
29.
30.

Biological regulation of testicular angiotensin I-converting enzyme.

Velletri PA, Lovenberg W.

Adv Exp Med Biol. 1986;198 Pt A:487-94.

PMID:
3028068
31.

Evidence for specific methylenedioxymethamphetamine (ecstasy) binding sites in the rat brain.

Gehlert DR, Schmidt CJ, Wu L, Lovenberg W.

Eur J Pharmacol. 1985 Dec 10;119(1-2):135-6. No abstract available.

PMID:
2867919
32.
33.
34.

In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat.

Schmidt CJ, Lovenberg W.

Neurosci Lett. 1985 Aug 16;59(1):9-14.

PMID:
2413404
35.

Vasopressin-induced calcium increases in smooth muscle cells from spontaneously hypertensive rats.

Nabika T, Velletri PA, Beaven MA, Endo J, Lovenberg W.

Life Sci. 1985 Aug 12;37(6):579-84.

PMID:
4021731
36.

Lack of evidence supporting a role for dopamine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

Schmidt CJ, Bruckwick E, Lovenberg W.

Eur J Pharmacol. 1985 Jul 11;113(1):149-50. No abstract available.

PMID:
2864262
37.

Endocrinological control and cellular localization of rat testicular angiotensin-converting enzyme (EC 3.4.15.1).

Velletri PA, Aquilano DR, Bruckwick E, Tsai-Morris CH, Dufau ML, Lovenberg W.

Endocrinology. 1985 Jun;116(6):2516-22.

PMID:
2986952
38.

Is Ca2+-calmodulin-dependent protein phosphorylation in rat brain modulated by carboxylmethylation?

Billingsley ML, Velletri PA, Lovenberg W, Kuhn D, Goldenring JR, DeLorenzo RJ.

J Neurochem. 1985 May;44(5):1442-50.

PMID:
3989542
39.
40.

CSF dopamine-beta-hydroxylase activity in Parkinson's disease.

Hurst JH, LeWitt PA, Burns RS, Foster NL, Lovenberg W.

Neurology. 1985 Apr;35(4):565-8.

PMID:
3982644
41.

Thermal denaturation of rat pulmonary and testicular angiotensin-converting enzyme isozymes. Effects of chelators and CoCl2.

Velletri PA, Billingsley ML, Lovenberg W.

Biochim Biophys Acta. 1985 Mar 29;839(1):71-82.

PMID:
2983769
42.

Enhanced sympathetic-adrenal medullary response to cold exposure in spontaneously hypertensive rats.

Yamori Y, Ikeda K, Kulakowski EC, McCarty R, Lovenberg W.

J Hypertens. 1985 Feb;3(1):63-6.

PMID:
3998461
44.

Protein carboxylmethylation and nervous system function.

Billingsley ML, Lovenberg W.

Neurochem Int. 1985;7(4):575-87.

PMID:
20492963
45.
46.
47.
48.

The hypotensive action of 4-(5,6-dimethyl-2-benzofuranyl) piperidine HCl (CGP 6085 A) in spontaneously hypertensive rats.

Kulakowski EC, Hurst JH, Scheinin M, Linnoila M, Lovenberg W.

Clin Exp Hypertens A. 1985;7(4):585-604.

PMID:
2408794
49.

Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor.

Buck SH, Burcher E, Shults CW, Lovenberg W, O'Donohue TL.

Science. 1984 Nov 23;226(4677):987-9.

PMID:
6095447
50.

The hypothermic effect of 4-(5,6-dimethyl-2-benzofuranyl) piperidine HCl (CGP 6085 A) in Wistar Kyoto rats.

Kulakowski EC, Hurst JH, Miller T, Linnoila M, Lovenberg W.

Life Sci. 1984 Sep 17;35(12):1329-35.

PMID:
6237238

Supplemental Content

Loading ...
Support Center